These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 6325480

  • 1. Corticosteroids in neurologic disease.
    Ellison GW.
    Hosp Pract (Off Ed); 1984 Apr; 19(4):105-9, 113-5. PubMed ID: 6325480
    [No Abstract] [Full Text] [Related]

  • 2. [ACTH and corticosteroid treatment for neurological diseases (author's transl)].
    Neundörfer B.
    Nervenarzt; 1981 Aug; 52(8):431-40. PubMed ID: 6269011
    [No Abstract] [Full Text] [Related]

  • 3. Adrenal steroid therapy in neurological disease. Part I.
    Eisen AA, Norris JW.
    Can Med Assoc J; 1969 Jan 04; 100(1):27-30. PubMed ID: 4388115
    [No Abstract] [Full Text] [Related]

  • 4. Corticosteroids and corticotrophin in the treatment of neurologic disorders, with emphasis on neurologic disorders of childhood.
    Chutorian AM.
    Clin Neuropharmacol; 1982 Jan 04; 5(3):239-65. PubMed ID: 6288235
    [No Abstract] [Full Text] [Related]

  • 5. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG.
    Bibl Psychiatr Neurol; 1969 Jan 04; 139():36-59. PubMed ID: 4332888
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W.
    Med Welt; 1969 Nov 29; 48():2636-49. PubMed ID: 4318400
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Steroids in neurology.
    Wiles CM.
    Br J Hosp Med; 1982 Oct 29; 28(4):308, 313-6, 321-2. PubMed ID: 7139155
    [No Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 10. Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids.
    Baumann J.
    Acta Neurol Scand Suppl; 1965 Jun 30; 13 Pt 2():453-61. PubMed ID: 4284452
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Glucocorticoids--pro and contra. Possibilities for use of dexamethasone in neurology and neurosurgery (II)].
    Schulte RM.
    Med Welt; 1983 Jul 15; 34(28):793-8. PubMed ID: 6350805
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Use of adrenal cortex hormones in neurological diseases].
    Tsukagoshi H.
    Naika; 1965 Jul 15; 16(1):108-11. PubMed ID: 4287135
    [No Abstract] [Full Text] [Related]

  • 18. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG, Berger CL, Namba T, Grob D.
    Ann N Y Acad Sci; 1976 Jul 15; 274():577-95. PubMed ID: 183590
    [Abstract] [Full Text] [Related]

  • 19. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J.
    Tidsskr Nor Laegeforen; 1971 Apr 20; 91(11):821-4. PubMed ID: 4326179
    [No Abstract] [Full Text] [Related]

  • 20. Corticotropin is superior to corticosteroids in the treatment of MS.
    Poser CM.
    Arch Neurol; 1989 Sep 20; 46(9):946. PubMed ID: 2549925
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.